Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Zubida M. Al-Majdoub

The University of Manchester

United Kingdom

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Pharmacology

100%

Biochemistry

100%

Metabolic Biology

70%

Transporter Biology

60%

Pharmacogenomic

50%

Pharmacokinetic

40%

Metabolomic

30%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles17

Dealing With Variable Drug Exposure Due to Variable Hepatic Metabolism: A Proof‐of‐Concept Application of Liquid Biopsy in Renal Impairment

Article Link

Year:

2024

Quantitative Proteomics for Translational Pharmacology and Precision Medicine: State of The Art and Future Outlook

Article Link

Year:

2024

Complementarity of two proteomic data analysis tools in the identification of drug-metabolising enzymes and transporters in human liver

Article Link

Year:

2024

Complementarity of two proteomic data analysis tools in the identification of drug-metabolising enzymes and transporters in human liver

Article Link

Year:

2024

Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis

Article Link

Year:

2023

Proteomic quantification of receptor tyrosine kinases involved in the development and progression of colorectal cancer liver metastasis

Article Link

Year:

2023

Toward systems-informed models for biologics disposition: covariates of the abundance of the neonatal Fc Receptor (FcRn) in human tissues and implications for pharmacokinetic modelling

Article Link

Year:

2023

Quantitative Assessment of the Impact of Crohn's Disease on Protein Abundance of Human Intestinal Drug-Metabolising Enzymes and Transporters

Article Link

Year:

2022

A family of QconCATs (Quantification conCATemers) for the quantification of human pharmacological target proteins

Article Link

Year:

2022

Label-Free but Still Constrained: Assessment of Global Proteomic Strategies for the Quantification of Hepatic Enzymes and Transporters

Article Link

Year:

2022

Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P‐Glycoprotein Activities

Article Link

Year:

2022

Examining Physiologically-Based Pharmacokinetic (PBPK) Model Assumptions for Cross-Tissue Similarity of Kcat: The Case Example of Uridine 5'-diphosphate Glucuronosyltransferase (UGT)

Article Link

Year:

2022

In Vitro to In Vivo Extrapolation Linked to Physiologically Based Pharmacokinetic Models for Assessing the Brain Drug Disposition

Article Link

Year:

2022

Quantitative Assessment of the Impact of Crohn's Disease on Protein Abundance of Human Intestinal Drug-Metabolising Enzymes and Transporters

Article Link

Year:

2022

Quantitative Proteomic Map of Enzymes and Transporters in the Human Kidney: Stepping Closer to Mechanistic Kidney Models to Define Local Kinetics

Article Link

Year:

2021

Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage Adjustment

Article Link

Year:

2021

Inhibition of aggregation of amyloid-β through covalent modification with benzylpenicillin; potential relevance to Alzheimer’s disease

Article Link

Year:

2021

Collaborators5

Brahim Achour

Assistant Professor

University of Rhode Island

UNITED STATES

Nigel Hodson

The University of Manchester

UNITED KINGDOM

Kayode Ogungbenro

Lecturer

The University of Manchester

UNITED KINGDOM

Daniel Scotcher

The University of Manchester

UNITED KINGDOM

Amin Rostami-Hodjegan

The Director & Professor of Systems Pharmacology

The University of Manchester

UNITED KINGDOM

How do I reach out?

Meet Kite AI